Members access evidence-based protocols for immune-modulating peptides, detailed safety guides for autoimmune-specific considerations, dosing calculators tailored to individual needs, and a community of researchers navigating the complex intersection of peptide science and autoimmune disease management
An overview of acetic acid ulcer modelsthe history and state of the art of peptic ulcer research
Animal Early human IBD/ulcerative-colitis trials of BPC-157 (PL-14736) reported it as safe with no reported toxicity but these clinical trials were not completed or fully published
A third midday dose, if hunger allows sufficient fasting time, further elevates GH throughout the day
The safety assessment is based on the independent safety profiles of each compound (GLP-1 medications through extensive FDA trials, BPC-157 through decades of preclinical research), their non-overlapping mechanisms, and growing clinical experience from physicians who prescribe both